

Cytek Biosciences (NASDAQ:CTKB) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Cytek Biosciences (NASDAQ:CTKB) through any online brokerage.
Other companies in Cytek Biosciences’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Cytek Biosciences has a consensus price target of $5.15.
The stock price for Cytek Biosciences (NASDAQ: CTKB) is $5.895 last updated November 9, 2026 at 3:52 PM EST.
There are no upcoming dividends for Cytek Biosciences.
Cytek Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Cytek Biosciences.
Cytek Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish...